uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Genetics and Pathology.
Show others and affiliations
2005 (English)In: Experimental Cell Research, ISSN 0014-4827, E-ISSN 1090-2422, Vol. 308, no 2, 381-393 p.Article in journal (Other academic) Published
Abstract [en]

The mechanisms controlling blood vessel formation during early embryonal development have only partly been elucidated. Shb is an adaptor protein previously implicated in the angiogenic response to vascular endothelial growth factor (VEGF). To elucidate a possible role of Shb in embryonic vascular development, wild-type and SH2 domain mutated (R522K) Shb were overexpressed in murine embryonic stem (ES) cells. Embryoid bodies (EBs) differentiating from Shb-overexpressing ES cells in vitro were stained for CD31 or VEGFR-2 to visualize the formation of vascular structures. We found that Shb promotes the outgrowth of blood vessels in EBs both in the absence and presence of growth factors. This response may be the consequence of an increased number of VEGFR-2 positive cells at an early stage of EB development, a finding corroborated by both immunostaining and real-time RT-PCR. In addition, Shb overexpression upregulated the expression of PDGFR-beta, CD31, CD41 and Tal1. Cells co-expressing VEGFR-2 and PDGFR-beta were commonly observed when Shb was overexpressed and inhibition of PDGF-BB signaling reduced the amount of VEGFR-2 mRNA under these conditions. EBs expressing the Shb R522K-mutant did not form vascular structures. Microarray analysis of VEGFR-2/CD31 positive cells after 6 days of differentiation revealed numerous changes of expression of genes relating to an endothelial/hematopoietic phenotype in response to Shb overexpression. The findings suggest that Shb may play a crucial role during early ES cell differentiation to vascular structures by transducing VEGFR-2 and PDGFR-beta signals.

Place, publisher, year, edition, pages
2005. Vol. 308, no 2, 381-393 p.
Keyword [en]
Animals, Antigens; CD31/metabolism, Blood Vessels/cytology/*embryology/*metabolism, Cell Differentiation/physiology, Cell Line, DNA-Binding Proteins/genetics/metabolism, Embryo Culture Techniques, Endothelial Cells/cytology/metabolism, Gene Expression Profiling, Gene Expression Regulation; Developmental/physiology, Mice, Mutation/genetics, Neovascularization; Physiologic/*physiology, Oligonucleotide Array Sequence Analysis, Phenotype, Platelet Membrane Glycoprotein IIb/genetics/metabolism, Pluripotent Stem Cells/cytology/*metabolism, Proto-Oncogene Proteins/genetics/*metabolism, RNA; Messenger/metabolism, Receptor; Platelet-Derived Growth Factor beta/*metabolism, Research Support; Non-U.S. Gov't, Signal Transduction/physiology, Transcription Factors/genetics/metabolism, Up-Regulation/*physiology, Vascular Endothelial Growth Factor Receptor-2/genetics/*metabolism
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-74355DOI: 10.1016/j.yexcr.2005.04.020PubMedID: 15919073OAI: oai:DiVA.org:uu-74355DiVA: diva2:102265
Note

De två första författarna delar förstaförfattarskapet.

Available from: 2005-09-22 Created: 2005-09-22 Last updated: 2013-04-03Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15919073&dopt=Citation

Authority records BETA

Rolny, CharlotteÅgren, NinaNilsson, IngridWelsh, Michael

Search in DiVA

By author/editor
Rolny, CharlotteÅgren, NinaNilsson, IngridWelsh, Michael
By organisation
Department of Medical Cell BiologyDepartment of Genetics and Pathology
In the same journal
Experimental Cell Research
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 805 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf